Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04856566 · ClinicalTrials.gov registry record · Early Phase 1
Examine the Feasibility of a Standardized Field Test for Marijuana and Alcohol Impairment: Laboratory Evaluations
A Early Phase 1 study of Alcohol Impairment and Marijuana Impairment, sponsored by Yale University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 41
- Enrollment target
- 1
- Study location
NCT04856566 is a Early Phase 1 study of Alcohol Impairment and Marijuana Impairment that has completed, run by Yale University. The registered enrollment target is 41 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04856566, a Early Phase 1 study of Alcohol Impairment and Marijuana Impairment, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 41 participants
- Enrollment target
- 1
- Study location
Study Summary
Alcohol and Cannabis (CNB) are two of the most widely used intoxicants. The effects of driving while intoxicated on alcohol are well documented, resulting in numerous drunken driving laws and regulations. As CNB begins to be decriminalized, medical CNB use allowed in multiple U.S. states, and perception of harmfulness falls, CNB use is predicted to rise and it will become increasingly common to publicly encounter persons who recently used the drug. An area of potentially high concern is if ever-greater numbers of CNB users and its legalization will increase the risk of driving while intoxicated from recent CNB use, thereby increasing the risks to public safety. This study aims to examine the combined effects of smoking marijuana and drinking alcohol on simulated driving.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Low Marijuana, Hash, THC, or Grass
- DRUG High Marijuana, Hash, THC, or Grass
- DRUG 0.05 BAC Alcohol
- DRUG 0.08 BAC Alcohol
Study Locations (1)
Connecticut
- Hartford Hospital - Hartford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2021-07-28 |
| Est. Completion | 2023-08-23 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04856566
The ClinicalTrials.gov registry entry for NCT04856566 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Alcohol Impairment appearing as the primary indexed condition, and to 5 interventions - of which Placebo is the first listed.
NCT04856566 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT04856566 about?
NCT04856566 is a clinical study titled "Examine the Feasibility of a Standardized Field Test for Marijuana and Alcohol Impairment: Laboratory Evaluations". Alcohol and Cannabis (CNB) are two of the most widely used intoxicants. The effects of driving while intoxicated on alcohol are well documented, resulting in numerous drunken driving laws and regulations. As CNB begins to be decriminalized, medical CNB use allowed in multiple U.S. states, and percep...
What is the current status of trial NCT04856566?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 41 participants. The study started on 2021-07-28. Estimated completion is 2023-08-23.
What conditions does trial NCT04856566 study?
This clinical trial studies the following conditions: Alcohol Impairment, Marijuana Impairment.
What interventions are being tested in trial NCT04856566?
The interventions under investigation include: Placebo (DRUG), Low Marijuana, Hash, THC, or Grass (DRUG), High Marijuana, Hash, THC, or Grass (DRUG), 0.05 BAC Alcohol (DRUG), 0.08 BAC Alcohol (DRUG).
Who is sponsoring clinical trial NCT04856566?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04856566 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Impairment
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.